Wealth Enhancement Advisory Services, LLC Axsome Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $44.5 Billion
- Q3 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 19,808 shares of AXSM stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,808
Previous 19,054
3.96%
Holding current value
$1.8 Million
Previous $1.53 Million
16.05%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$380 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$362 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$299 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$214 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$94.9 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.89B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...